The programmed cell death-1 (PD-1)/ programmed cell death ligand-1 (PD-L1) pathway represents an adaptive immune resistance mechanism exerted by tumor cells in response to endogenous immune anti-tumor activity [8, 9]. The gene discussed is PDCD1; the disease is neoplasm.